Because of the central role of EWS-FLI1 in establishing the enhancer landscape in Ewing sarcoma, we made significant modifications of the method by requiring that all candidate TFs have both EWS-FLI1 binding motif and binding peaks in their assigned super-enhancers. This evidence concerns the gene FLI1 and Ewing sarcoma.